1. Home
  2. MRX vs KYMR Comparison

MRX vs KYMR Comparison

Compare MRX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRX
  • KYMR
  • Stock Information
  • Founded
  • MRX 2005
  • KYMR 2015
  • Country
  • MRX United Kingdom
  • KYMR United States
  • Employees
  • MRX N/A
  • KYMR N/A
  • Industry
  • MRX
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • MRX
  • KYMR Health Care
  • Exchange
  • MRX NYSE
  • KYMR Nasdaq
  • Market Cap
  • MRX 2.5B
  • KYMR 2.2B
  • IPO Year
  • MRX 2024
  • KYMR 2020
  • Fundamental
  • Price
  • MRX $34.48
  • KYMR $29.62
  • Analyst Decision
  • MRX Strong Buy
  • KYMR Buy
  • Analyst Count
  • MRX 8
  • KYMR 13
  • Target Price
  • MRX $34.63
  • KYMR $56.69
  • AVG Volume (30 Days)
  • MRX 487.4K
  • KYMR 597.4K
  • Earning Date
  • MRX 03-06-2025
  • KYMR 05-01-2025
  • Dividend Yield
  • MRX 1.22%
  • KYMR N/A
  • EPS Growth
  • MRX 49.45
  • KYMR N/A
  • EPS
  • MRX 2.72
  • KYMR N/A
  • Revenue
  • MRX $2,356,700,000.00
  • KYMR $47,072,000.00
  • Revenue This Year
  • MRX N/A
  • KYMR $44.93
  • Revenue Next Year
  • MRX $10.53
  • KYMR N/A
  • P/E Ratio
  • MRX $12.68
  • KYMR N/A
  • Revenue Growth
  • MRX 25.22
  • KYMR N/A
  • 52 Week Low
  • MRX $18.13
  • KYMR $29.07
  • 52 Week High
  • MRX $40.05
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • MRX N/A
  • KYMR 33.94
  • Support Level
  • MRX N/A
  • KYMR $29.83
  • Resistance Level
  • MRX N/A
  • KYMR $35.28
  • Average True Range (ATR)
  • MRX 0.00
  • KYMR 1.79
  • MACD
  • MRX 0.00
  • KYMR -0.20
  • Stochastic Oscillator
  • MRX 0.00
  • KYMR 4.54

About MRX MAREX GROUP PLC

Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: